Mimedx (MDXG) Cash from Operations Growth (5y) (2016 - 2026)
Powered by 
Analysis
Mimedx (MDXG) Cash from Operations Growth (5y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 126.82 Bn | 121.60 Bn | 1.96 Bn |
| 3 | Medtronic | 117.93 Bn | 109.11 Bn | 6.34 Bn |
| 4 | Stryker | 104.83 Bn | 101.36 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.14 Bn | 30.20 Bn | 830.00 Mn |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn |
| 10 | Mimedx | 673.21 Mn | 537.37 Mn | 44.38 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -52.56% |
| Mar 31, 2026 | 17.93% |
| Dec 31, 2025 | 34.68% |
| Sep 30, 2025 | 52.88% |
| Jun 30, 2025 | 46.10% |
| Mar 31, 2025 | 19.45% |
| Dec 31, 2024 | 22.97% |
| Sep 30, 2024 | 52.36% |
| Jun 30, 2024 | 59.43% |
| Mar 31, 2024 | 19.58% |
| Dec 31, 2023 | 43.30% |
| Sep 30, 2023 | 30.99% |
| Jun 30, 2023 | -4.29% |
| Mar 31, 2023 | -19.11% |
| Dec 31, 2022 | -17.81% |
| Sep 30, 2022 | -44.34% |
| Jun 30, 2022 | -17.32% |
| Mar 31, 2022 | -24.25% |
| Dec 31, 2021 | -22.48% |
| Sep 30, 2021 | 17.34% |